Defence Therapeutics Stock Market Value
| DTCFF Stock | USD 0.41 0.00 0.00% |
| Symbol | Defence |
Defence Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Defence Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Defence Therapeutics.
| 12/22/2022 |
| 12/11/2024 |
If you would invest 0.00 in Defence Therapeutics on December 22, 2022 and sell it all today you would earn a total of 0.00 from holding Defence Therapeutics or generate 0.0% return on investment in Defence Therapeutics over 720 days. Defence Therapeutics is related to or competes with Sino Biopharmaceutica, Aileron Therapeutics, Enlivex Therapeutics, Lixte Biotechnology, Benitec Biopharma, Cingulate, and XOMA. Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biologicalbiosimilar ther... More
Defence Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Defence Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Defence Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 25.87 | |||
| Value At Risk | (2.44) |
Defence Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Defence Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Defence Therapeutics' standard deviation. In reality, there are many statistical measures that can use Defence Therapeutics historical prices to predict the future Defence Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | 1.03 |
Defence Therapeutics Backtested Returns
Defence Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0491, which denotes the company had a -0.0491% return per unit of risk over the last 3 months. Defence Therapeutics exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Defence Therapeutics' Standard Deviation of 3.22, mean deviation of 1.04, and Variance of 10.39 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.16, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Defence Therapeutics are expected to decrease at a much lower rate. During the bear market, Defence Therapeutics is likely to outperform the market. At this point, Defence Therapeutics has a negative expected return of -0.16%. Please make sure to confirm Defence Therapeutics' variance and the relationship between the maximum drawdown and day typical price , to decide if Defence Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.65 |
Good predictability
Defence Therapeutics has good predictability. Overlapping area represents the amount of predictability between Defence Therapeutics time series from 22nd of December 2022 to 17th of December 2023 and 17th of December 2023 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Defence Therapeutics price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Defence Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
Defence Therapeutics lagged returns against current returns
Autocorrelation, which is Defence Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Defence Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Defence Therapeutics returns to help us make a trade decision. For example, suppose you find that Defence Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Defence Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Defence Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Defence Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Defence Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Defence Therapeutics Lagged Returns
When evaluating Defence Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Defence Therapeutics otc stock have on its future price. Defence Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Defence Therapeutics autocorrelation shows the relationship between Defence Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Defence Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Defence OTC Stock
Defence Therapeutics financial ratios help investors to determine whether Defence OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Defence with respect to the benefits of owning Defence Therapeutics security.